You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML il-6 tocilizumab

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Registry Study of Takayasu Arteritis in East China

Recruiting
  • Takayasu Arteritis
  • +4 more
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021

Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)

Active, not recruiting
Has Results
  • Leukemia, Acute Myeloid (AML)
  • Birmingham, Alabama
  • +125 more
Aug 9, 2022

TAKAYASU ARTERITIS Trial in Saint-Antoine (Tocilizumab)

Completed
  • TAKAYASU ARTERITIS
  • Saint-Antoine, Paris, France
    Department of internal medicine
Aug 17, 2020

MDD Trial (Tocilizumab, Placebo, Whole-Body Hyperthermia)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Aug 23, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)

Terminated
  • Arthritis, Rheumatoid
  • Interaction
  • Esbjerg, Region Of Southern Denmark, Denmark
  • +2 more
Jan 20, 2023

Acute Myeloid Leukemia, Vitamin D Deficiency, ADAMTS13 Trial in Cairo (Cholecalciferol 2800 I.U. ml oral drops)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Cholecalciferol 2800 I.U. ml oral drops
  • Cairo, Madinaty, Egypt
    Dina Ashraf Abdelhady
Nov 25, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

Active, not recruiting
  • Rejection Chronic Renal
  • Kidney Transplant Rejection
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 18, 2022

    Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

    Completed
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 4, 2023

    Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)

    Not yet recruiting
    • Sickle Cell Disease
    • Acute Chest Syndrome
    • (no location specified)
    Nov 28, 2022

    Solid Tumor, Colitis, Arthritis Trial in Herlev (Tocilizumab (RoACTEMRA®))

    Completed
    • Solid Tumor
    • +2 more
    • Tocilizumab (RoACTEMRA®)
    • Herlev, Denmark
      Herlev & Gentofte University Hospital, Denmark
    Apr 18, 2020

    Heart Arrest, Out-Of-Hospital Cardiac Arrest, Systemic Inflammatory Response Syndrome Trial in Copenhagen (Tocilizumab 20 Mg/mL

    Completed
    • Heart Arrest
    • +2 more
    • Tocilizumab 20 Mg/mL Intravenous Solution
    • isotonic saline
    • Copenhagen, Denmark
      Rigshospitalet
    Aug 20, 2020

    Lung Cancer Squamous Cell Trial in Stuttgart, Tuebingen (CC-1 and Toczilizumab)

    Recruiting
    • Lung Cancer Squamous Cell
    • CC-1 and Toczilizumab
    • Stuttgart, BW, Germany
    • +1 more
    Feb 2, 2022

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

    Recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • San Francisco, California
    • +1 more
    Oct 8, 2022

    Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Carmel, Indiana
    • +2 more
    Apr 27, 2023

    Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia

    Not yet recruiting
    • Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
      • (no location specified)
      Nov 30, 2022

      COVID-19 Pneumonia Trial in Doha (Colchicine)

      Recruiting
      • COVID-19 Pneumonia
      • Doha, DA, Qatar
        Alaa Rahal
      Nov 22, 2021

      Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

      Active, not recruiting
      • Hematologic Malignancy
      • Milwaukee, Wisconsin
        Froedtert Hospital
      Jan 31, 2023

      Acute Leukemia, Chronic Leukemia, Lymphoma Trial in Milwaukee (Nivolumab (.25 mg/kg), Tocilizumab, Nivolumab (.5 mg/kg))

      Terminated
      • Acute Leukemia
      • +3 more
      • Nivolumab (.25 mg/kg)
      • +2 more
      • Milwaukee, Wisconsin
        Froedtert Hospital and the Medical College of Wisconsin
      Oct 4, 2021

      Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +41 more
      • Ipilimumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 11, 2022

      COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)

      Recruiting
      • COVID-19
      • Hospitalized COVID-19 Patients
      • Lopinavir / Ritonavir
      • +3 more
      • Zgharta, North, Lebanon
      • +1 more
      Jun 28, 2023

      Breast Cancer Trial in Fayoum (Tocilizumab, traditional Covid -19 therapy)

      Completed
      • Breast Cancer
      • Fayoum, Egypt
        ALsafwa specialized hospital
      Oct 31, 2022